You want to know whether Trump legalized medical marijuana. A final order, signed by the Acting Attorney General and published April 28, 2026, moved qualifying state-licensed medical marijuana from Schedule I to Schedule III. It does not authorize recreational marijuana, and marijuana outside its scope remains in Schedule I. DEA has started registering dispensaries.
What the order changes for you, and what it leaves alone
The change covers a defined group. The final order, published April 28, 2026, moves products containing marijuana that are covered by a qualifying state-issued license to Schedule III. The final order does not authorize recreational marijuana. Marijuana outside its scope stays Schedule I, and broader rescheduling is being considered in a separate administrative proceeding.
The dates you need to know
Status as of November 2, 2026. These are the dates you need for the medical side.
| Date | What happened |
|---|---|
| April 23, 2026 | The April 23 order under 21 U.S.C. 811(d) begins the change. Treasury said the same day it plans tax guidance on the order. |
| April 28, 2026 | Final order published. The timely window for applications opens. |
| June 26, 2026 | The timely window closes. It was the expedited window, not the only time to apply. |
| July 15, 2026 | The broader rescheduling hearing ends after 11 days. |
| October 30, 2026 | DEA issues the first federal registrations to more than 900 dispensaries. |
| November 5, 2026 | Reply briefs are due in the broader rescheduling process. The hearing process is on hold until at least this date. |
| November 29, 2026 | Timely applicants are expected to finish verification and set up compliant supply chains. |
Has DEA registered any medical marijuana dispensaries?
Yes, in a first phase. On October 30, 2026, the Justice Department press release announced initial registrations for more than 900 dispensaries in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia. Each dispensary had to finish DEA’s pre-registration investigation first. State licensure alone does not grant federal registration.
DOJ has not named the registered businesses. The AP report in the Los Angeles Times adds that registration could pave the way for tax benefits the industry has long been denied.
Applications in the timely window ran from April 28 to June 26, 2026. The DEA’s guidance for timely applicants defines them as businesses that submitted a complete application, including the fee, in that window. DEA has since opened a new Schedule III registration portal for manufacturers, distributors and labs, so applications did not close on June 26. DEA says it will not prioritize those applications until it has processed the timely applicants.
If you deal with timely applicants, verify their document control number on DEA’s Diversion Control website. The guidance frames that check as due diligence for businesses, not as a tool for consumers.
Minnesota: an order to show cause, not a final denial
Minnesota shows how the process can go against a state’s license type. According to the Minnesota Star Tribune and Marijuana Moment, DEA delivered an order to show cause on October 30 to In-Dispensary, a Minneapolis business. The order says Minnesota’s dual-purpose license, which permits medical and non-medical dispensing, falls outside the definition of a state medical marijuana license. In-Dispensary can request a hearing within 30 days or submit a corrective action plan.
A show cause order is not a final denial. DEA’s guidance treats an application as ended only by withdrawal or a final order denying it. Minnesota’s Office of Cannabis Management says the letter does not affect state law, and medical cannabis remains available to patients in the state. Minnesota had 30 businesses file timely applications, including 26 dispensaries.
Which states applied, and what about Kansas and Texas?
Cannabis Business Times reports that DEA released a list of nearly 7,000 timely applicants on October 30. The list gives business types and states, not business names. These are the states with the most applicants, counting all business types:
| State | Timely applicants, all types |
|---|---|
| Oklahoma | 2,442 |
| Florida | 812 |
| California | 771 |
| Maine | 320 |
| Pennsylvania | 227 |
| Missouri | 209 |
Texas is among the states with dispensaries in the first registrations. Florida is the country’s largest medical-only market, according to MJBizDaily.
The AP report says 40 states have medical marijuana systems, eight others allow low-THC cannabis or CBD oil for medical use, and only Idaho and Kansas ban marijuana outright. For how the medical marijuana question plays out in the Kansas race, the site’s Kansas governor race on medical marijuana coverage goes further. For Kansas campaign coverage, see Trump’s Kansas Senate endorsement.
Where supporters and critics stand
Supporters say the change widens access. Attorney General Todd Blanche said “The American people deserve access to the best medical treatments in the world,” and that regulated distribution by registered applicants “will help ensure broader access to chronic pain treatment.” Steph Sherer of Americans for Safe Access called it “a tremendous victory for patient access.”
You deserve straight answers about how the rules will work. Mark Eide, owner of In-Dispensary, said DEA told him it was serving many other people with the same document. Neil Willner, an attorney at Vicente LLP, said DEA appears to be testing whether a whole state can be disqualified rather than judging an individual applicant. Gillian Schauer of the Cannabis Regulators Association said state regulators got no notice. She listed open questions about how DEA will buy and resell marijuana, how it will coordinate with states, and its enforcement priorities. Carol Moss, a cannabis attorney, said businesses in dual-market states may miss the Schedule III tax benefit even if they are not in recreational sales.
Chris Lindsey of the American Trade Association for Cannabis and Hemp said the industry wants to know what to expect now that companies will operate in this class.
What about taxes?
Treasury’s April 23, 2026 press release says rescheduling generally removes the Section 280E bar for businesses that no longer traffic in Schedule I or II substances. It expects guidance on businesses with multiple activities. The release does not make DEA registration a condition for the benefit. The DOJ order says qualifying state licensees should consult tax counsel. To see whether that guidance has been issued, the IRS is the place to check.
What you can do now
- If you are a patient, check your state’s medical program and your state health department or cannabis regulator; your state license rules still govern what you can buy.
- If you run or work for a dispensary, check DEA’s Diversion Control website for the guidance for timely applicants and the registration portal.
- If you are worried about taxes, watch the IRS for the guidance Treasury said it expects, and talk to tax counsel.
What is still open
- DOJ has not named the registered dispensaries.
- It is unclear what requirements DEA may impose, including on owners with criminal histories.
- The broader rescheduling hearing is on hold until at least November 5. After that, the judge must certify the record and make a nonbinding recommendation to DEA Administrator Terry Cole.
- Adult-use marijuana remains Schedule I, with no clear timeline for a separate process.
- For state-by-state legalization dates, your state’s health department or cannabis regulator is the right place to start.
By USPatriotNews.com Editorial Team
